2018-03925. Wyeth Pharmaceuticals Inc. et al.; Withdrawal of Approval of 121 New Drug Applications and 161 Abbreviated New Drug Applications; Correction  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Notice; correction.

    SUMMARY:

    The Food and Drug Administration (FDA) is correcting a notice that appeared in the Federal Register of June 21, 2017 (82 FR 28322). The document announced the withdrawal of approval of 121 new drug applications (NDAs) and 161 abbreviated new drug applications from multiple applicants, withdrawn as of July 21, 2017. The document indicated that FDA was withdrawing approval of NDA 204508, Clinolipid 20% (olive oil and soybean oil) USP, 16%/4%, after receiving a request from the NDA holder, Baxter Healthcare Corp. (Baxter), 32650 N Wilson Rd., Round Lake, IL 60073. Before the approval of NDA 204508 was withdrawn, Baxter informed FDA that it did not want the approval of this NDA withdrawn. Because Baxter timely requested that approval of this NDA not be withdrawn, the approval of NDA 204508 is still in effect.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Florine Purdie, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 6366, Silver Spring, MD 20993-0002, 301-796-3601.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In the Federal Register of Wednesday, June 21, 2017, appearing on page 28322 in FR Doc. 2017-12908, the following correction is made:

    On page 28329, in table 1, the entry for NDA 204508 is removed.

    Start Signature

    Dated: February 21, 2018.

    Leslie Kux,

    Associate Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. 2018-03925 Filed 2-26-18; 8:45 am]

    BILLING CODE 4164-01-P

Document Information

Published:
02/27/2018
Department:
Food and Drug Administration
Entry Type:
Notice
Action:
Notice; correction.
Document Number:
2018-03925
Pages:
8485-8485 (1 pages)
Docket Numbers:
Docket No. FDA-2017-N-3203
PDF File:
2018-03925.Pdf